Healthcare - Biotechnology - NASDAQ - US
$ 3.345
-6.95 %
$ 439 M
Market Cap
-1.54
P/E
INCOME STATEMENT
0
REVENUE
-191 M
OPERATING INCOME
-198 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Prime Medicine, Inc.
| Revenue | 0 |
| Cost Of Revenue | 148 M |
| Gross Profit | -148 M |
| Operating Expenses | 187 M |
| Operating Income | -191 M |
| Other Expenses | 6.84 M |
| Net Income | -198 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 5.2 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 147.9 | 0 | 0 | 0 | 2.8 |
| Gross Profit | (147.9) | 0 | 0 | 0 | (2.8) |
| OPERATING INCOME | |||||
| Operating Expenses | 186.6 | 116.5 | 84.5 | 6.1 | 2.2 |
| Selling, General and Administrative Expenses | 38.7 | 29.8 | 13.9 | 3.2 | 1.3 |
| Research and Development Expenses | 147.9 | 86.7 | 70.5 | 3.0 | 0.9 |
| Operating Income | (191.3) | (116.5) | (84.5) | (0.9) | (2.2) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 12.1 | 0 | 0 | 0 |
| Total Other Income | (7.1) | (6.2) | (81.4) | (0.6) | 4.0 |
| Pre-Tax Income | (198.4) | (122.8) | (165.9) | (1.5) | (2.5) |
| NET INCOME | |||||
| Tax Provision | (0.3) | (0.9) | (0.5) | 1.9 | 4 K |
| Net Income | (198.1) | (121.8) | (165.4) | (3.4) | (2.5) |
| EPS | 2.18 | 1.25 | 2.55 | 0.0704 | 0.0264 |